Clearant Reports Record Preliminary Q1 2008 Revenue Results
1st Quarter Revenue Increases 46% vs Q4 Results Clearant, owner of the Clearant Process? designed to substantially reduce all types of pathogens in biological products including HIV, announced that preliminary revenues for Q1 period ending 3/31/2008 increased 46% to $0.47 mln compared to $0.32 mln in Q4 2007.]]>